Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: PTCT stock price vs WPC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WPC's multiple
Needs WPC P/E.
Implied fair value · at PTCT's multiple
Needs PTCT P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PTCT FY 2025 (ended Dec 31, 2025) · WPC FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
PTC Therapeutics, Inc. · implied price per share
Bear
$79.76
Base
$93.84
Bull
$107.91
W. P. Carey Inc. · implied price per share
Bear
$35.30
Base
$41.53
Bull
$47.76
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-2.79x
0.20x
Net debt / EBITDA
Leverage against operating earnings
-1.83x
1.23x
Cash and equivalents
Liquid reserves on the balance sheet
$1.95B
$155.33M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
VERTEX PHARMACEUTICALS INC / MA
PTCT vs VRTX
Sarepta Therapeutics, Inc.
PTCT vs SRPT
BIOMARIN PHARMACEUTICAL INC
PTCT vs BMRN
ALNYLAM PHARMACEUTICALS, INC.
PTCT vs ALNY
ALEXANDRIA REAL ESTATE EQUITIES, INC.
PTCT vs ARE
Brixmor Property Group Inc.
PTCT vs BRX
KIMCO REALTY CORP
PTCT vs KIM
REALTY INCOME CORP
PTCT vs O
ESSENTIAL PROPERTIES REALTY TRUST, INC.
PTCT vs EPRT
$572.04M
$1.64B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
Live quote
